Loading...
10 21 19
05:41 AM

  $202.72

Sector
Manufacturing COMPARE IN SECTOR
Industry
Company Info - Overview CLICK HERE TO GET INFO

Valuation

Market Capitalization (D) 123.66B
Trailing P/E (D) 16.04
Price / Sales (D) 5.25
Price / Book (D) 11.46
Book Value Per Share (Q) 17.70
Basic EPS (Q) 3.59
Diluted EPS (Q) 3.57
Ex-Date (Q) 08/14/2019
Dividend Per Share (Q) 1.45
Annual Yield (D) 2.80%

RANKING PERFORMANCE LAST 30 DAYS


30-DAY STOCK PERFORMANCE RANKING (out of 6118 companies)


0-30 DAYS 30-60 DAYS 60-90 DAYS 90-120 DAYS 120-150 DAYS 150-180 DAYS
2628 199 2565 1492 3067 2038
180-210 DAYS 210-240 DAYS 240-270 DAYS 270-300 DAYS 300-330 DAYS 330-360 DAYS
3164 611 2145 939 1080 1266

Company Description

Amgen was incorporated in California in 1980 and became a Delaware corporation in 1987. Amgen operates in one business segment: human therapeutics. Amgen Inc. is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology. Amgen focuses on areas of high unmet medical need and leverages its biologics manufacturing expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.

Range: 3m 6m 1y 2y max

No Chart Information

Profitability  

Gross Margin (TTM) 82.17%    0.09%
Net Profit Margin (TTM) 33.77%    0.23%

Efficiency  

Return on Assets (TTM) 13.40%    0.79%
Return on Equity (TTM) 73.73%    0.82%

Liquidity  

Current Ratio (Q) 2.89    4.63%
Quick Ratio (Q) 2.41    1.67%

Capital Structure  

Debt:Equity (Q) 4.50    8.3%
Debt:Asset (Q) 0.82    1.51%

Miscellaneous  

Basic Average Shares Outstanding (Q) 607.00M    2.41%
Fully Diluted Average Shares Outstanding (Q) 610.00M    2.56%